Bellerophon Therapeutics Q3 EPS $(0.06) Up From $(0.1) YoY

Bellerophon Therapeutics (NASDAQ:BLPH) reported quarterly losses of $(0.06) per share. This is a 40 percent increase over losses of $(0.1) per share from the same period last year.

Benzinga · 11/06/2019 13:55

Bellerophon Therapeutics (NASDAQ:BLPH) reported quarterly losses of $(0.06) per share. This is a 40 percent increase over losses of $(0.1) per share from the same period last year.